Figure 5.

Renal clearance for 1,5-anhydroglucitol and glucose before and during EMPA treatment for PT2. Renal clearance of 1,5-AG increases in parallel to the glucose clearance in 24-hr urine collections for PT2, indicating that glucosuria prevents the renal uptake of 1,5-AG and results in its urinary excretion.